thiocolchicoside - apollo pharmaapollopharma.in/pdf/thiocolchicoside.pdf · description...
TRANSCRIPT
Thiocolchicoside | apollo +9191 46 950 950
Thiocolchicoside | apollo +9191 46 950 950
Thiocolchicoside
CAS Number : 602-41-5
Molecular Formula : C27H33NO10S
Molecular Weight : 563.618 g/mol
Systematic (IUPAC) : N-[(7S)-3-(beta-D-glucopyranosyloxy)
-1,2-dimethoxy-10-(methylsulfanyl)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide
Thiocolchicoside is a muscle relaxant. (Thiocolchicoside), a muscle relaxant agent with anti-
inflammatory and analgesic actions, also is used topically for the treatment of muscular spasms and for rheumatologic, orthopedic, and traumatologic disorders.
Description
Thiocolchicoside, a semi-synthetic derivative of the naturally occurring compound colchicoside with a relaxant effect on skeletal muscle, has been found to
displace both [3H]gamma-aminobutyric acid ([3H]GABA) and [3H]strychnine binding, suggesting an interaction with both GABA and strychnine-sensitive glycine receptors. In order to gain further insight into the interaction of thiocolchicoside with these receptors, the binding of [3H]thiocolchicoside in rat spinal cord-
brainstem and cortical synaptic membranes was characterized. [3H]Thiocolchicoside binding was saturable in both tissues examined. In spinal cord-
brainstem membranes, we found a K(D) of 254 +/- 47 nM and a Bmax of 2.39 +/- 0.36 pmol/mg protein,
whereas in cortical membranes, a K(D) of 176 nM and a Bmax of 4.20 pmol/mg protein was observed. A similar K(D) value was found in kinetic experiments performed in spinal cord-brainstem membranes. Heterologous displacement experiments showed that GABA and
strychnine displaced the binding in a dose-dependent manner, whereas glycine was ineffective.
[3H]Thiocolchicoside binding was also displaced by several GABA(A) receptor agonists and antagonists, but not by baclofen, flunitrazepam, guvacine, picrotoxin or by other drugs unrelated to GABA transmission. In
spinal cord-brainstem, and to a lower extent, in cortical membranes, GABA and its analogs were not able to completely displace [3H]thiocolchicoside specific
binding indicating that, besides GABA(A) receptors, thiocolchicoside can bind to another unidentified site. Unlabelled thiocolchicoside, however, completely
displaced [3H]muscimol binding both in cortical and in
spinal cord-brainstem synaptic membranes with an IC50 in the low microM range. Neurosteroids were found to modulate the binding in cortical but not in spinal cord-brainstem synaptic membranes. We
conclude that [3H]thiocolchicoside binding shows a pharmacological profile indicating an interaction with the GABA(A) receptor. The different affinities for the GABA(A) receptor agonists and antagonists and
sensitivity to neurosteroids obtained in the cerebral cortex and in the spinal cord may indicate a preferential
interaction of the compound with a subtype of the GABA(A) receptor. The data also indicate that
[3H]thiocolchicoside binds to another site(s), whose nature remains to be elucidated.I
Mechanisms of action
Central action: blocking of the synapses of the medullary interneurones and under cortical.No the effect on the junction myoneuronale nor on muscle fibre.Inhibit the reflexes polysynaptic, without touching with the arc
reflexe elementary monosynaptic.Decrease the influence of the réticulée formation downward facilitatrice on the gamma activity, from where reduction in muscular hypertonicity.Would be a agonist Gabaergique:-
Therapie 1981;36:95-102
Pharmacology & Toxicology
Thiocolchicoside, a semi-synthetic derivative of the naturally occurring compound colchicoside with
a relaxant effect on skeletal muscle, has been found to displace both [3H]gamma-amino butyric acid
([3H]GABA) and [3H]strychnine binding, suggesting an interaction with both GABA and
strychnine-sensitive glycine receptors. Potent competitive antagonist of GABA function. A muscle
relaxant and displays anti-inflammatory and analgesic properties. Shows strong epileptogenic and
convulsing activity.
Side effects
Side effect of skeletal muscle relaxants may include: sedation, drowsiness, blurred or double vision,
constipation or diarrhea, dizziness and drowsiness, nervousness and confusion, dry mouth, dyspepsia
(chronic or recurrent pain in the upper abdomen, upper abdominal fullness, and feeling full earlier than expected when eating), fatigue, headache, heartburn, hiccups and nausea, insomnia, stomach cramps, trembling, vomiting, and weakness; and possible dependence following long-
term use.
Also known as Tiocolquicosido.
apollo | asia Division
APOLLO Pharmaceuticals
API Manufacturers INDIA [P] Ltd.|asia Division
Mr.Vipin Saxena|CEO
Cellular:+91-98-21050033
Cellular:+91-98-20150033
Direct :+91-22-65785588
FAX :+91-22-42950001
Wireline Purchase HELPDESK:
+91-22-65050001
+91-22-65650001
Wireline Sales HELPDESK:
+91-22-65500009
+91-22-65050009
Wireless 24x7 HELPDESK:
+9191-46-951951
+9191-46-950950
Blackberry Pin :
32E6500D | 32E65010 | 28415C58
Email:
www.apolloworld.in
www.apollopharma.in
www.apollopharmaceuticals.Net
Chat:
MSN Hotmail:VipinrSaxena
Skype NAME:VipinrSaxena
Rocketmail:VipinrSaxena
Google mail:VipinrSaxena
BlackBerry:28415C58
Regd. Office :-
1104, Maker Chamber V,
Nariman Point
Mumbai, INDIA
Pin:400021
Industrial Office
D-62, OIC India
Oshiwara Industrial Centre,
New Link Road,
Goregoan West,
Mumbai, INDIA
Pin:400104
Manufacturing Unit Address:
Plot No. 117A,
Village: Chamble
Near MonaTona Limited.Wada,
Maharashtra,
PIN : 421312 | INDIA
Email:
www.apollo.mn | www.apollo.com.co | www.apollopharmaceuticals.Com